StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn r&d expenses

Research and development expenses are spending on new products and technology.

CytoDyn's R&D Expenses for the twelve months ending May 31, 2024 was $7.24M. For fiscal 2024 it was $7.24M, up 175.1% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $53.40M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024May 31, 2024$7.24M+175.1%
FY2023May 31, 2023$2.63M-90.3%
FY2022May 31, 2022$27.04M-49.4%
FY2021May 31, 2021$53.40M+1.4%
FY2020May 31, 2020$52.64M+23.9%
FY2019May 31, 2019$42.49M+11.2%
FY2018May 31, 2018$38.22M+89.2%
FY2017May 31, 2017$20.21M+47.1%
FY2016May 31, 2016$13.73M-9.4%
FY2015May 31, 2015$15.16M+280.7%
FY2014May 31, 2014$3.98M+542.3%
FY2013May 31, 2013$619.84K+16.9%
FY2012May 31, 2012$530.03K+10.2%
FY2011May 31, 2011$480.77K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ2 2024May 31, 2024$3.60M+2525.5%
Q3 FY2024CQ1 2024Feb 29, 2024$650.00K+12.8%
Q2 FY2024CQ4 2023Nov 30, 2023$1.08M-73.1%
Q1 FY2024CQ3 2023Aug 31, 2023$1.91M-46.4%
Q2 FY2023CQ4 2022Nov 30, 2022$137.00K-98.2%
Q1 FY2023CQ3 2022Aug 31, 2022$576.00K-95.2%
Q4 FY2022CQ2 2022May 31, 2022$4.01M-57.1%
Q3 FY2022CQ1 2022Feb 28, 2022$3.57M-71.0%
Q2 FY2022CQ4 2021Nov 30, 2021$7.45M-54.7%
Q1 FY2022CQ3 2021Aug 31, 2021$12.02M-20.9%
Q4 FY2021CQ2 2021May 31, 2021$9.34M-53.2%
Q3 FY2021CQ1 2021Feb 28, 2021$12.32M-18.4%
Q2 FY2021CQ4 2020Nov 30, 2020$16.45M+92.9%
Q1 FY2021CQ3 2020Aug 31, 2020$15.19M+67.7%
Q4 FY2020CQ2 2020May 31, 2020$19.95M+116.9%
Q3 FY2020CQ1 2020Feb 29, 2020$15.11M+67.5%
Q2 FY2020CQ4 2019Nov 30, 2019$8.53M-33.7%
Q1 FY2020CQ3 2019Aug 31, 2019$9.06M-20.6%
Q4 FY2019CQ2 2019May 31, 2019$9.20M+3.1%
Q3 FY2019CQ1 2019Feb 28, 2019$9.02M-25.3%
Q2 FY2019CQ4 2018Nov 30, 2018$12.87M+41.8%
Q1 FY2019CQ3 2018Aug 31, 2018$11.40M+39.9%
Q4 FY2018CQ2 2018May 31, 2018$8.92M+59.2%
Q3 FY2018CQ1 2018Feb 28, 2018$12.08M+84.8%
Q2 FY2018CQ4 2017Nov 30, 2017$9.08M+107.1%
Q1 FY2018CQ3 2017Aug 31, 2017$8.15M+121.1%
Q4 FY2017CQ2 2017May 31, 2017$5.60M–
Q3 FY2017CQ1 2017Feb 28, 2017$6.53M–
Q2 FY2017CQ4 2016Nov 30, 2016$4.38M–
Q1 FY2017CQ3 2016Aug 31, 2016$3.69M–

More CytoDyn figures

See a number that looks wrong?